Jared Collins, DO
Clinical Cardiac Electrophysiology · Bradenton, FLNPI 1891087979
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Boston Scientific at 43.8% of the total. Reporting peaked in 2019 at $10,154 and has fallen 86.3% since, to $1,388 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.
Across 460 payments — averaging $38.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Medtronic$5K
- Biosense Webster, Inc.$2K
- Cvrx, Inc.$747
- Abbott$653
- Philips North America LLC$328
- plus $2K from 28 others
What the payments were for
- Consulting fees$4002%
- Travel & lodging$7,99945%
- Food & beverage$9,27152%
- Education$820%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 190 | $7,783 |
| Medtronic(2 entities) | 32 | $4,881 |
| Biosense Webster, Inc. | 112 | $1,536 |
| Cvrx, Inc. | 24 | $747 |
| Abbott | 9 | $653 |
| Philips North America LLC | 6 | $328 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $227 |
| Amgen | 12 | $184 |
| Elutia, Inc. | 8 | $175 |
| Pfizer | 6 | $111 |
| Boehringer Ingelheim | 5 | $92 |
| Abiomed | 3 | $88 |
| Innovation Technologies Inc | 2 | $84 |
| Novartis | 4 | $83 |
| AstraZeneca | 5 | $76 |
| Cardiva Medical, Inc. | 1 | $66 |
| Novo Nordisk | 3 | $66 |
| Merck | 3 | $63 |
| Johnson & Johnson(2 entities) | 3 | $58 |
| Inari Medical, Inc. | 2 | $49 |
| Stryker | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $48 |
| Kestra Medical Technology Services, Inc. | 2 | $44 |
| Braemar Manufacturing, LLC | 1 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Circa Scientific, Inc. | 1 | $30 |
| Biotronik Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Volta Medical Inc | 1 | $22 |
| Cleerly, Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| Terumo Medical Corporation | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$3,491
- GENERAL - THERAPIES$1,264
- Barostim Neo System$429
- LATITUDE Communicator Power Supply$400
- Micra$296
- EMBLEM$197
- Ensite Cardiac Mapping System$161
- Azure$156
- WATCHMAN Access System$146
- RESONATE EL ICD VR$136
- AMPLATZER PICCOLO$135
- RESONATE$115
- MitraClip$114
- Bridge$108
- ENSITE PRECISION$108
How this compares
$17,752 in reported general payments places this provider in the 35th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 273 | $331,822 |
| XareltoRivaroxaban | 67 | $72,619 |
| EntrestoSacubitril/Valsartan | 28 | $27,004 |
| Repatha SureclickEvolocumab | 20 | $15,514 |
| Flecainide Acetate | 121 | $4,921 |
| Dofetilide | 17 | $4,622 |
| Ranolazine ErRanolazine | 17 | $3,588 |
| Metoprolol Succinate | 190 | $2,598 |
| Propafenone Hcl ErPropafenone Hcl | 15 | $2,589 |
| Amiodarone Hcl | 34 | $2,102 |
| Rosuvastatin Calcium | 119 | $1,857 |
| Propafenone Hcl | 13 | $1,350 |
| Atorvastatin Calcium | 133 | $1,178 |
| Valsartan | 60 | $1,177 |
| ClopidogrelClopidogrel Bisulfate | 104 | $1,177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $111 | $331,822273 claims |
| Johnson & JohnsonXarelto | $58 | $72,61967 claims |
| NovartisEntresto | $83 | $27,00428 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Bradenton
- Daniel FriedmanBradenton$226K
- Rajesh MalikBradenton$54K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.